Gene editing is becoming an increasingly common remedy for a variety of ailments, and Boulder area bioscience companies are leading those advancements. Building on research and technology originating at University of Colorado Boulder, several front range companies are employing CRISPR to create new breakthroughs.

“There’s a hotbed of chemistry associated with gene editing here,” said David Sebesta, chief commercial officer of KromaTiD.

Find out how Colorado companies are using “one of the most promising scientific developments of the 21st century” to do gene editing work at the same level of the coastal powerhouses in this Denver Business Journal article.